AzTrials
AzTrials

Febrile IllnessNCT06959420

Knowledge, Attitudes, Perceptions and Behaviors of Healthcare Professionals and the General Population Regarding Vaccination During Febrile Illness

An observational study of Febrile Illness, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Patients and healthcare professionals often lack adequate information regarding the possibility of vaccinating during febrile illnesses due to limited data. French guidelines on this topic remain vague, placing the responsibility for decision-making on healthcare professionals. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Febrile Illness
What is being tested?
Questionnaire
Type of treatment
Vaccines
How many people
630 participants
Where
1 siteFrance
Study dates
18 Mar 2025to 10 Oct 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: People in the general population and healthcare professionals concerned by vaccination.

Who may be able to join

  • Healthcare professionals : to administer vaccines as part of their usual practice
  • General population: adults aged 18 years old and over.

Who cannot join

  • Healthcare professionals: professionals that do not vaccinate patients in their usual practice.
  • General population : individuals under the age of 18 years old.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Soumaya Essalim, PhD student contact

(0)477829222 ext. +33

Soumaya.Essalim@chu-st-etienne.fr

France1 site, 1 recruiting
  • CHU Saint-Etienne

    Saint-Etienne, France, 42055

    Recruiting

Other trials in France

About this study

Patients and healthcare professionals often lack adequate information regarding the possibility of vaccinating during febrile illnesses due to limited data. French guidelines on this topic remain vague, placing the responsibility for decision-making on healthcare professionals. This lack of clear guidance, combined with a perceived low urgency for vaccination in such cases, frequently leads to postponements, resulting in missed vaccination opportunities.

By investigating the knowledge, attitudes, perceptions, and behaviors of both patients and healthcare professionals, the investigators can identify obstacles and leverage incentives to promote vaccination during mild febrile illnesses. This approach could help reduce missed opportunities and improve vaccine coverage overall.

Conditions
Febrile Illness
Being tested
Questionnaire
Keywords
Vaccination, Immunization, Febrile illness, Mild fever, Efficacy, Safety

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    Anonymous self-administered questionnaire on the Limesurvey platform.

Study groups in NCT06959420
Study groupRoleWhat they receive
Healthcare professionalsHealth professionals who administer vaccines as part of their usual practice.
Receives: Other: Questionnaire
General populationAdults aged 18 years old and over
Receives: Other: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Population in favour of vaccination during febrile periods

    Proportion of the general population and healthcare professionals in favour of vaccination during febrile periods

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2025
  2. Study start18 Mar 2025
  3. Primary completion1 Oct 2027 (estimated)
  4. Study completion10 Oct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrolment
630 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06959420
Sponsor's protocol ID
IRBN322025
Status last verified
Oct 2026
First submitted
28 Apr 2025
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Febrile Illness, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Soumaya Essalim, PhD student ((0)477829222 ext. +33, Soumaya.Essalim@chu-st-etienne.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Population in favour of vaccination during febrile periods (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in